ĀÜĄņĀŅĀ×

Brenda Jeglinski is an accomplished leader in clinical operations with extensive experience in the pharmaceutical industry. Currently serving as the VP and Head of Clinical Operations at Boston Pharmaceuticals since April 2021, Brenda previously held key positions such as Head of Clinical Operations at Neurogastrx, Inc. from July 2018 to April 2021 and Senior Director of Clinical Operations at Verastem from November 2016 to July 2018. Brenda's career includes progressive roles in clinical operations at notable companies such as Verastem, WAVE Life Sciences, Sideris Pharmaceuticals, and Ironwood Pharmaceuticals, where Brenda developed robust expertise in managing and directing clinical programs.